Results 41 to 50 of about 28,334 (206)

Regulating Reprogenetics: Strategic Sacralisation and Semantic Message [PDF]

open access: yes, 2007
This paper forms part of the feminist critique of the regulatory consequences of biomedicine's systematic exclusion of the role of women's bodies in the development ofreprogenetic technologies.
Mackenzie, Robin
core   +1 more source

Two means two, but must does not mean must:an analysis of recent decisions on the conditions for parental orders in surrogacy [PDF]

open access: yes, 2018
This article examines the High Court decisions in Re Z (A Child) (Surrogate Father: Parental Order) [2017] 1 FLR 472 and Re X (A Child) (Parental Order: Time Limit) [2015] 1 FLR 349, which concerned two of the conditions for the granting of ‘parental ...
Brown, Alan
core  

Clinical Characteristics Associated With Very Preterm Delivery Despite Transabdominal Cerclage: A Cohort Study

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To identify factors associated with unsuccessful transabdominal cerclage (TAC) insertion, defined as delivery before 32 weeks, including maternal demographics, preterm birth risk factors, operative details (laparoscopic or open, pre‐pregnancy or during pregnancy) and subsequent cervical length.
Laura van der Krogt   +3 more
wiley   +1 more source

Surrogate mother – praiseworthy or stigmatized: a qualitative study on perceptions of surrogacy in Assam, India

open access: yesGlobal Health Action, 2017
Background: Surrogacy is a reproductive practice that has been strongly marketed in India as a solution for childless couples. As a result, the number of surrogacy clinics is increasing.
Anna Arvidsson   +3 more
doaj   +1 more source

Experiences of Women and Clinicians During the Introduction of Uterine Transplantation to the UK: A Qualitative Case Study

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To explore the experiences of women and clinicians during the introduction of uterine transplantation (UTx) to the UK. Design A qualitative study utilising prospective case study methodology (interviews and observations) over 6 years.
Daisy Elliott   +13 more
wiley   +1 more source

Clinical complete response as a surrogate for pathological response in bladder cancer: a systematic review and meta‐analysis

open access: yesBJU International, EarlyView.
Objective To evaluate the concordance between clinical complete response (cCR) and pathological complete response (pCR) in muscle‐invasive bladder cancer (MIBC) to assess the surrogacy and prognostic value of cCR for guiding bladder‐sparing strategies.
Navid Roessler   +15 more
wiley   +1 more source

A case for paid surrogate motherhood [PDF]

open access: yes, 2008
It has become commonplace to distinguish between altruistic and commercial surrogate motherhood. Altruistic surrogacy refers to cases where the surrogate mother is motivated by care or concern for an infertile couple, usually friends or relatives, to ...
van Zyl, Liezl
core   +1 more source

Assisted Regulation: Argentine Courts Address Regulatory Gaps on Surrogacy [PDF]

open access: yesHealth and Human Rights, 2023
Surrogacy operates in a regulatory void in Argentina. Despite attempts to legislate this practice, Argentine law contains no univocal rules governing the legality and enforceability of surrogacy agreements.
Patricio López Turconi
doaj  

Estimating Treatment Effects using Multiple Surrogates: The Role of the Surrogate Score and the Surrogate Index

open access: yes, 2020
Estimating the long-term effects of treatments is of interest in many fields. A common challenge in estimating such treatment effects is that long-term outcomes are unobserved in the time frame needed to make policy decisions.
Athey, Susan   +3 more
core  

Acalabrutinib in Chronic Lymphocytic Leukemia: Pharmacology and Emerging Clinical Perspectives

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Acalabrutinib, a second‐generation Bruton's tyrosine kinase inhibitor (BTKi), is characterized by enhanced specificity and selectivity for BTK with minimal off‐target effects, offering a significant evolution in the treatment of chronic lymphocytic leukemia (CLL). Its mechanism of action, a covalent binding to Cys481 within the BTK active site,
Gianluca Gaidano, Romano Danesi
wiley   +1 more source

Home - About - Disclaimer - Privacy